Protective immunity after recovery from SARS-CoV-2 infection.

Kojima, Noah; Klausner, Jeffrey D

Kojima, Noah; Klausner, Jeffrey D.

Kojima N; Department of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. Electronic address: nkojima@ucla.edu.
Klausner JD; Departments of Population Health and Public Health Sciences and Medicine, Keck School of Medicine, University Southern California, Los Angeles, CA, USA.

Lancet Infect Dis ; 22(1): 12-14, 2022 01.

Article in English | MEDLINE | ID: covidwho-1594944

Subject(s)

Antibodies, Neutralizing/blood; Antibodies, Viral/blood; COVID-19/immunology; Immunity; Reinfection/immunology; SARS-CoV-2/immunology; Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; Humans; Reinfection/virology; SARS-CoV-2/pathogenicity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Reinfection / SARS-CoV-2 / COVID-19 / Immunity / Antibodies, Viral Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google